Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | CTSD | P07339 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.30 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8333479 | 0.84 | POLB (0.40) | MEN1KMT2APOLBHTTKDM4E | |
| SCHEMBL9366706 | 0.81 | TSHR (0.34) | HDAC4HDAC6 | |
| SCHEMBL28475922 | 0.79 | ITGB3 (0.33) | HDAC4HDAC6 | |
| SCHEMBL9544888 | 0.79 | GAA (0.37) | MEN1KMT2APOLBHTTKDM4E | |
| SCHEMBL9300620 | 0.79 | HTT (0.41) | POLBHTTKDM4EMAPTCTSD | |
| SCHEMBL8335975 | 0.78 | GAA (0.44) | MEN1KMT2APOLBHTTKDM4E | |
| SCHEMBL10743893 | 0.78 | TSHR (0.37) | HDAC4HDAC6 | |
| SCHEMBL10740515 | 0.74 | KMT2A (0.32) | MEN1KMT2AHTT | |
| SCHEMBL536355 | 0.74 | — | — | |
| SCHEMBL8336929 | 0.74 | HDAC4 (0.36) | KMT2AKDM4EHDAC4HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9238609-B2 | Dicarboxylic acid monomers and methods of making and using the same | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2016-01-19 | — | — | US | disclosed |
| US-20150336869-A1 | DICARBOXYLIC ACID MONOMERS AND METHODS OF MAKING AND USING THE SAME | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2015-11-26 | — | — | US | disclosed |
| US-20150322200-A1 | AMORPHOUS POLYESTER COMPOSITIONS | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2015-11-12 | — | — | US | disclosed |
| US-8633265-B2 | UV stabilization of isosorbide polycarbonates | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2014-01-21 | — | — | US | disclosed |
| CN-103328570-A | UV stabilization of isosorbide polycarbonates | SABIC INNOVATIVE PLASTICS IP | 2013-09-25 | — | — | CN | disclosed |
| US-20120184651-A1 | UV Stabilization of Isosorbide Polycarbonates | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2012-07-19 | — | — | US | disclosed |
| US-RE34791-E | Polymer bound hindered amine light stabilizers | ATOCHEM NORTH AMERICA, INC. (US) | 1994-11-15 | — | — | US | disclosed |
| EP-0303987-B1 | POLYMER BOUND HINDERED AMINE LIGHT STABILIZERS | ATOCHEM NORTH AMERICA, INC. (US) | 1992-10-14 | — | — | EP | disclosed |
| US-4978699-A | Reaction product of hindered amine with primary amine or reactive hydrazide group and halogenated cyclic anhydride; for extrusion with polymers | ATOCHEM NORTH AMERICA, INC. (US) | 1990-12-18 | — | — | US | disclosed |
| US-4975489-A | Heating an anhydride-containing polymer with a hydrazine derivative of a 2,2,6,6-tetramethyl-4-aminopiperidine in an inert solvent of by melt blending | ATOCHEM NORTH AMERICA, INC. (US) | 1990-12-04 | — | — | US | disclosed |
| US-4857595-A | Polymer bound hindered amine light stabilizers | PENNWALT CORPORATION (US) | 1989-08-15 | — | — | US | disclosed |
| US-4824884-A | Cyclic anhydride derivatives of hydrazide functionalized hindered amine light stabilizers | PENNWALT CORPORATION (US) | 1989-04-25 | — | — | US | disclosed |
| EP-0303282-A2 | Cyclic anhydride derivatives of hydrazide functionalized hindered amine light stabilizers | ATOCHEM NORTH AMERICA, INC. (US) | 1989-02-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150336869-A1 | DICARBOXYLIC ACID MONOMERS AND METHODS OF MAKING AND USING THE SAME | PGD, CDA, PPIA | MEN1 2424/4885KMT2A 1712/4885POLB 937/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.